PTLF (Petlife Pharmaceuticals) Other Current Payables: $0.07 Mil (As of Feb. 2018)


What is Petlife Pharmaceuticals Other Current Payables?

Petlife Pharmaceuticals PTLF Other Current Payables is $0.07 Mil as of Feb. 2018.

Petlife Pharmaceuticals's Other Current Payables for the quarter that ended in Feb. 2018 was $0.07 Mil.

Petlife Pharmaceuticals's quarterly Other Current Payables increased from Aug. 2017 ($0.01 Mil) to Nov. 2017 ($0.13 Mil) but then declined from Nov. 2017 ($0.13 Mil) to Feb. 2018 ($0.07 Mil).

Petlife Pharmaceuticals's annual Other Current Payables increased from Aug. 2015 ($0.14 Mil) to Aug. 2016 ($2.33 Mil) but then declined from Aug. 2016 ($2.33 Mil) to Aug. 2017 ($0.01 Mil).

Petlife Pharmaceuticals Other Current Payables Related Terms

Petlife Pharmaceuticals Other Current Payables Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Other Current Payables Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.14 2.33 0.01

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.34 0.01 0.13 0.07

Petlife Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.07 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Other Current Payables of $0.07 Mil as of Feb. 2018. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Other Current Payables too high?
Petlife Pharmaceuticals' current Other Current Payables is $0.07 Mil.
How does Petlife Pharmaceuticals' Other Current Payables compare to PCYN and YBAO?
Petlife Pharmaceuticals' Other Current Payables of $0.07 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Other Current Payables is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Other Current Payables of $0.07 Mil. The current Other Current Payables is $0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Other Current Payables is $0.07 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.